SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-013225
Filing Date
2021-03-03
Accepted
2021-03-03 17:28:52
Documents
2
Period of Report
2021-02-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea136963-8k_cmlife2.htm 8-K 23920
2 AUDITED BALANCE SHEET AS OF FEBRUARY 25, 2021 ea136963ex99-1_cmlife2.htm EX-99.1 89487
  Complete submission text file 0001213900-21-013225.txt   114524
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 21710675
SIC: 6770 Blank Checks